Immunotherapy Could Restore Fertility in Early Menopause
A pilot study from Karolinska Institutet indicates that immunotherapy using the drug rituximab may help restore fertility in women with autoimmune premature ovarian insufficiency. Three participants in the study successfully gave birth to healthy babies following the treatment.
Why it matters
This offers a potential breakthrough for treating infertility caused by autoimmune conditions, which currently affects a significant percentage of women.
A pilot study from Karolinska Institutet shows that immunotherapy may enable stimulation of egg maturation in women with autoimmune POI (premature ovarian insufficiency) - a condition that usually leads to infertility. Three out of ten women gave birth to healthy babies following the treatment.
The article reports on scientific findings from a medical study without editorializing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in